Doctor Russell Foxall | University of Southampton

Publications

11 publications

Page 1 of 2

CD40L and IL-4 lymph node-associated signals protect B cells from rituximab-induced ADCC via KIR and NKG2A

Lara V. Graham, Russell B. Foxall, Margaret Ashton-Key, Salim I. Khakoo, Souraya Sayegh, Maria Leandro, Venkat R. Reddy, Mark S. Cragg & Matthew D. Blunt, 2026, Clinical and Experimental Immunology, 220(1)

DOI: 10.1093/cei/uxag001

Type: article

CD40L and IL-4 suppress NK cell-mediated antibody-dependent cellular cytotoxicity through the HLA-E:NKG2A axis

Lara V. Graham, Ludmila Horehajova, Marco V. Haselager, Jack G. Fisher, Jamie Lee Roos, Russell B. Foxall, Mel John, Kerry L. Cox, Robert J. Oldham, Martin C. Taylor, Margaret Ashton-Key, Ben Sale, Laura G. Bartlett, Ali Roghanian, Eric Eldering, Andres F. Vallejo, Francesco Forconi, Salim I. Khakoo, Mark S. Cragg & Matthew D. Blunt, 2025, Immunotherapy Advances, 5(1)

DOI: 10.1093/immadv/ltaf029

Type: article

The ETS-family transcription factor PU.1 is a critical regulator of the inhibitory Fcγ receptor IIB expression in humans

Matthew J. Carter, Yury D. Bogdanov, Rosanna C. Smith, Kerry L. Cox, Sarah Frampton, Lili Ferson, Russell B. Foxall, Khiyam Hussain, Jonathan C. Strefford, Stephen A. Beers & Mark S. Cragg, 2025, Journal of Immunology, 214(8), 1937-1950

DOI: 10.1093/jimmun/vkaf109

Type: article

Development and characterisation of a novel 3D in vitro model of obesity-associated breast cancer as a tool for drug testing

Rhianna R.R. Blyth, Stèphanie A. Laversin, Russell B. Foxall, Constantinos Savva, Ellen Copson, Ramsey I. Cutress, Charles N. Birts & Stephen A. Beers, 2025, npj Breast Cancer, 11(1)

DOI: 10.1038/s41523-025-00766-3

Type: article

Comparison of human macrophages derived from peripheral blood and bone marrow

Hannah L. Smith, Russell B. Foxall, Patrick J. Duriez, Emma L. Teal, Adam D. Hoppe, Janos M. Kanczler, Juliet C. Gray & Stephen A. Beers, 2025, The Journal of Immunology, 214(4), 714-725

DOI: 10.1093/jimmun/vkae032

Type: article

49P metformin is associated with increased intratumoural immune infiltrates in patients with primary invasive breast cancer

C. Savva, C. Birts, R. Foxall, M. Ashton-Key, A.M. Thompson, S. Lord, L. Campo, S. Hadad, C.A. Purdie, P. Johnson, E. Copson, R. Cutress & S. Beers, 2023, ESMO open, 8(1)

DOI: 10.1016/j.esmoop.2023.101273

Type: conference

HIF activation enhances FcγRIIb expression on mononuclear phagocytes impeding tumor targeting antibody immunotherapy

Khiyam Hussain, Rena Liu, Rosanna C G Smith, Kri T J Müller, Mohammadmersad Ghorbani, Sofia Macari, Kirstie L S Cleary, Robert J Oldham, Russell B Foxall, Sonya James, Steven G Booth, Tom Murray, Lekh N Dahal, Chantal E Hargreaves, Robert S Kemp, Jemma Longley, James Douglas, Hannah Markham, Serena J Chee, Richard J Stopforth, Ali Roghanian, Matthew J Carter, Christian H Ottensmeier, Bjorn Frendéus, Ramsey I Cutress, Ruth R French, Martin J Glennie, Jonathan C Strefford, Stephen M Thirdborough, Stephen A Beers & Mark S Cragg, 2022, Journal of Experimental and Clinical Cancer Research, 41(131), 131

DOI: 10.1186/s13046-022-02294-5

Type: article

Prognostic significance of FCGR2B expression for the response of DLBCL patients to rituximab or obinutuzumab treatment

Malgorzata Nowicka, Laura K. Hilton, Margaret Ashton-Key, Chantal E Hargreaves, Chern Lee, Russell Foxall, Matthew Carter, Stephen A. Beers, Kathleen N. Potter, Christopher R. Bolen, Christian Klein, Andrea Knapp, Farheen Mir, Matthew Rose-Zerilli, Cathy Burton, Wolfram Klapper, David W. Scott, Laurie H. Sehn, Umberto Vitolo, Maurizio Martelli, Marek Trněný, Christopher K. Rushton, Graham W. Slack, Pedro Farinah, Jonathan C. Strefford, Mikkel Z. Oestergaard, Ryan D. Morin & Mark Cragg, 2021, Blood Advances, 5(15), 2945-2957

DOI: 10.1182/bloodadvances.2021004770

Type: article

Developing a 3D B cell Lymphoma culture system to model antibody therapy

Russell Foxall, Priyanka Narang, Bridget Glaysher, Elin Hub, Emma Louise Teal, Mark C. Coles, Margaret Ashton-Key, Stephen Beers & Mark Cragg, 2021, Frontiers in Immunology, 11

DOI: 10.3389/fimmu.2020.605231

Type: article

Cyclophosphamide enhances cancer antibody immunotherapy in the resistant bone marrow niche by modulating macrophage FcγR expression

Ali Roghanian, Guangan Hu, Christopher Fraser, Maneesh Singh, Russell Foxall, Matthew J. Meyer, Emma Lees, Heather Huet, Martin Glennie, Stephen Beers, Sean Lim, Margaret Ashton-Key, Stephen Thirdborough, Mark Cragg & Jianzhu Chen, 2019, Cancer Immunology Research, 7(11), 1876-1890

DOI: 10.1158/2326-6066.CIR-18-0835

Type: article

Dr Russell Foxall

Connect with Russell

Publications